Biofil Chemicals & Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 7.67 | 0.93 | 13.60 |
| Operating Expense | 7.13 | 0.76 | 13.43 |
| Net Profit | 0.21 | 0.08 | 0.08 |
| Net Profit Margin | 2.74% | 8.60% | 0.59% |
| Earning Per Share | 0.13 | 0.05 | 0.05 |
| EBIDTA | 0.28 | 0.18 | 0.18 |
| Effective Tax Rate | 0% | 17.65% | 16.67% |
Particulars
Mar 2026
Revenue7.67
Operating Expense7.13
Net Profit0.21
Net Profit Margin2.74
Earning Per Share0.13
EBIDTA0.28
Effective Tax Rate0
